White Paper: Unleashing the Power of Precision Medicine: Radioligand Therapy
This article was originally published on This Month in Transformative Medicine on October 17, 2023
The current standard of cancer care has saved many lives, but these methods often come with incredibly difficult side effects. Advancements in technology have brought new options to cancer care that hope to provide meaningful outcomes while minimizing the impact to the patient’s quality of life.
In this white paper Anshul Mangal, President of Project Farma (PF) & Precision ADVANCE, and Sumit Verma, Co-founder and Partner at Orchestra Life Sciences, discuss the power and potential of radioligand therapies and its impact on the treatment of a number of cancers.
On Demand: State of the Union for Advanced Therapies
Sponsored by Precision ADVANCE, this Endpoints webinar convened industry leaders to discuss the current state of the industry, and the future of advanced therapies including innovations in research and development, going from treating rare diseases to prevalent conditions, continued investment, and next-generation technologies. The panelists also discussed manufacturing and talent bottlenecks, and innovative reimbursement payment models. This discussion was moderated by Anshul Mangal: President (Precision ADVANCE & Project Farma), and included insights from Dan Kirby: Chief Commercial Officer (Orca Bio), Deborah Phippard: CSO (Precision for Medicine), Devyn Smith: CEO (Arbor Bio), Helen Sabzevari: President & CEO (Precigen) and Chad Salisbury: SVP (Project Farma).
Conference: Precision Attends HLTH, 2023
Precision will be at HLTH 2023, October 8 – 11, in Las Vegas, NV. Connect with our team of experts as they lead meaningful discussions and attend networking events focused on innovation and transformation for better patient health and treatment outcomes.
Connect with one our experts!
- Schedule a meeting with one our our experts by emailing precisionadvance@precisionmedicinegrp.com
- Join Precision’s Ashwin Athri: EVP, Strategy, Innovation, and Partnerships (Precision Value & Health) for an insightful panel session on Sunday, October 8th titled, “Digital Deliberations: The Ins and Outs of Implementing a Digital Strategy”
White Paper: Scaling Hope: The Growth of the Allogeneic Cell Therapy Sector
In the rapidly evolving landscape of advanced therapies, allogeneic cell therapies have emerged as a promising avenue for addressing various disorders, including hematological malignancies, neurological conditions, and autoimmune or inflammatory diseases. With a number of clinical trials underway to evaluate their efficacy, allogeneic cell therapies hold significant potential in reshaping the way we approach treating numerous diseases.
In this white paper, Anshul Mangal, President of Project Farma & Precision ADVANCE and John Khoury, Executive Vice President of Project Farma (PF), discuss the growth of the allogeneic cell therapy sector and its impact on patient access.
Conference: Association for Value-Based Cancer Care 2023 Educational Summit & Program
Precision will be at this year’s Association for Value-Based Cancer Care 2023 Educational Summit & Program, October 18 – 20, NYC, NY. This exclusive invitational forum provides invaluable time with more than 200 diverse experts representing every stakeholder of the cancer care ecosystem.
Don’t miss an opportunity to celebrate groundbreaking science and network with industry leaders!
- Schedule a meeting with one of our experts
Speaking Engagements
Detailed descriptions for each speaking engagement are included below.
- Precision’s, Phil Cyr: SVP (Precision Value & Health) will facilitate a panel session on Wednesday, October 18th titled, “Cell and Gene Therapy and the Future Impact on Cancer Care”
- Precision’s, Andy Kinley: VP, Innovation and Clinical Science (Precision for Medicine) will facilitate a panel session on Thursday, October 19th titled, “Evolution of Clinical Trials”
You can register for the Association for Value-Based Cancer Care 2023 Educational Summit & Program below: